Eldavojohn writes "MIT's telecommunications Review has the scoop on the first annual user embryology Show control gate today in Boston and it looks like the rage these days is genetic testing sans the middle-man physician. And it's getting more prevalent and more available: 'A number of companies beneficence direct-to-consumer genetic testing have cropped up in the past two years to capitalize on these advances, from 23andMe and Navigenics, which offer genome-wide scans to diagnosticate particular disease-linked genetic variations, to Knome, which offers whole-genome sequencing to the wealthy. Any doubts that privy genomics is making its way into the average can be assuaged with a look at Interleukin genetics, a startup that sells genetic tests for heart-disease risk, B vitamin metabolism, and other factors through Amway, the direct-sales company.' Over-the-counter genetic tests may be much closer than you think. The article raises referring to that this info* will be misused/misinterpreted or even provide a false sense of security. We've discussed some states prohibiting this last year."

Read more of this story at Slashdot.

More: - Continued here

Mark